Device follow-up for a small hole in the heart
Part of Genetic & congenital, Heart & circulation clinical trials.
This follow-up study monitors how well and how safely the Occlutech mVSD device works to close certain muscular heart “holes” (ventricular septal defects). You may join if you already had the device placed and can return for scheduled checkups to help doctors learn long-term outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a muscular ventricular septal defect that fits the device instructions for use (IFU).
- Your doctor says your heart condition is suitable for this closure (no listed contraindications).
- You can understand the study and agree to participate by signing informed consent.
- You’re able and willing to return for all follow-up visits and procedures.
- The study requires that you do NOT have any major exclusions, like active serious infection, certain allergies, or a too-small aortic rim.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
This study looks at how children and teens recover after closing a common heart hole (ventricular septal defect) using a special device placed through a tube. It aims to see if the closure works well and how the heart does over time.
This study gathers information on a procedure to close a specific type of heart hole using a device inserted through a catheter. It aims to evaluate how well this procedure works in different medical centers.
This study follows up with patients who already received the Cera ASD occluder device to close a hole in the heart (atrial septal defect). It looks at how well the device is working over time and checks for any late problems.
This study follows people with chronic heart failure to see how well an implanted device (called the Occlutech AFR) works and whether it is safe over time. It may help doctors better understand who benefits and how to manage treatment safely.
This study checks how well specific MicroPort CRM heart devices and leads work in real life over time. If you already have one of these FDA/market-approved implants and can be followed yearly, the study helps the company monitor safety and performance.
Hear when a new Muscular Ventricular Septal Defect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.